Peptides in Melanoma Therapy

Author(s): Simone Mocellin.

Journal Name: Current Pharmaceutical Design

Volume 18 , Issue 6 , 2012

Become EABM
Become Reviewer

Abstract:

Peptides derived from tumor associated antigens can be utilized to elicit a therapeutically effective immune response against melanoma in experimental models. However, patient vaccination with peptides - although it is often followed by the induction of melanoma- specific T lymphocytes - is rarely associated with tumor response of clinical relevance. In this review I summarize the principles of peptide design as well as the results so far obtained in the clinical setting while treating cutaneous melanoma by means of this active immunotherapy strategy. I also discuss some immunological and methodological issues that might be helpful for the successful development of peptide-based vaccines.

Keywords: Peptide, melanoma, therapy, immunotherapy, vaccine, diagnosis, vaccination, tumor, T lymphocytes, carcinomas

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 18
ISSUE: 6
Year: 2012
Page: [820 - 831]
Pages: 12
DOI: 10.2174/138161212799277734
Price: $58

Article Metrics

PDF: 9